Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 30;20(2):2310-22.
doi: 10.3390/molecules20022310.

Soy isoflavones in nutritionally relevant amounts have varied nutrigenomic effects on adipose tissue

Affiliations

Soy isoflavones in nutritionally relevant amounts have varied nutrigenomic effects on adipose tissue

Elena Giordano et al. Molecules. .

Abstract

Soy consumption has been suggested to afford protection from cardiovascular disease (CVD). Indeed, accumulated albeit controversial evidence suggests that daily consumption of ≥25 g of soy protein with its associated phytochemicals intact can improve lipid profiles in hypercholesterolemic humans. However, the belief that soy foods and supplements positively impact human health has become increasingly controversial among the general public because of the reported estrogenic activities of soy isoflavones. In this study, we investigated the nutrigenomic actions of soy isoflavones (in nutritionally-relevant amounts) with a specific focus on the adipose tissue, due to its pivotal role in cardiometabolism. Young C57BL/6 mice were maintained for eight weeks under two different diet regimes: (1) purified control diet; or (2) purified control diet supplemented with 0.45 g% soybean dry purified extract (a genistein/daidzein mix). Soy isoflavones increased plasma total cholesterol concentrations and decreased triglyceride ones. Circulating leptin levels was also increased by soy consumption. Differentially expressed genes in adipose tissue were classified according to their role(s) in cellular or metabolic pathways. Our data show that soy isoflavones, administered in nutritionally-relevant amounts, have diverse nutrigenomic effects on adipose tissue. Taking into account the moderate average exposure to such molecules, their impact on cardiovascular health needs to be further investigated to resolve the issue of whether soy consumption does indeed increase or decrease cardiovascular risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Leptin circulating concentrations in mice receiving either chow diet (control) or 0.45% Soyselect® during eight weeks (n = 7 per group). * p < 0.05 as compared with controls.
Figure 2
Figure 2
Venn diagram of selected pathway analyses. Pathway analyses of Soyselect®-modulated genes were performed and MAPK, TGFβ, and chemokine signaling were included as examples.
Figure 3
Figure 3
RT-qPCR validation of selected genes related to MAPK, TGFβ, chemokine signaling, and others related to lipid metabolism. Mice received either chow diet (ctrl) or 0.45% Soyselect® during eight weeks. mRNA is given as relative expression (n = 6 per group). * p < 0.05 as compared with controls.

Similar articles

Cited by

References

    1. Clifton P.M. Protein and coronary heart disease: The role of different protein sources. Curr. Atheroscler. Rep. 2011;13:493–498. doi: 10.1007/s11883-011-0208-x. - DOI - PubMed
    1. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: A summary of a statement for professionals from the american heart association nutrition committee. Arterioscler. Thromb. Vasc. Biol. 2006;26:1689–1692. doi: 10.1161/01.ATV.0000227471.00284.ef. - DOI - PubMed
    1. Talaei M., Koh W.P., van Dam R.M., Yuan J.M., Pan A. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J. Nutr. 2014;144:921–928. doi: 10.3945/jn.114.190454. - DOI - PMC - PubMed
    1. Visioli F. Nutritional support in the pharmacological treatment of metabolic syndrome. Eur. J. Pharmacol. 2011;668:S43–S49. doi: 10.1016/j.ejphar.2011.05.083. - DOI - PubMed
    1. Qin Y., Niu K., Zeng Y., Liu P., Yi L., Zhang T., Zhang Q.Y., Zhu J.D., Mi M.T. Isoflavones for hypercholesterolaemia in adults. Cochrane Database Syst. Rev. 2013;6:CD009518. doi: 10.1002/14651858.CD009518. - DOI - PMC - PubMed

Publication types

LinkOut - more resources